Clinical Trials Logo

Medulloblastoma, Childhood clinical trials

View clinical trials related to Medulloblastoma, Childhood.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03288168 Active, not recruiting - Clinical trials for Medulloblastoma, Childhood

Children's and Adolescents' Medulloblastoma Molecular Subgroups in China

CNOG-MB001
Start date: September 1, 2017
Phase:
Study type: Observational

Recently, diagnosis and treatments for medulloblastoma becomes more complicated than before since the new World Health Organization (WHO) diagnosis criteria has put molecular marker onto an ever important position. Reports and studies revealed highly correlated connection between subgroups of medulloblastoma and patient outcomes. Children's Oncology Group (COG) has launched many new studies on molecular subgroups-based specific treatment trails. In China, children and adolescents with brain tumor have been treated variously for a long time in lack of standardized comprehensive treatments. Same poor situation in basic research and clinical studies makes the Chinese children with brain tumor hardly catch up with international level in molecular diagnosis and specific treatments. There are limited studies, which were conducted by immunohistochemistry for identifying medulloblastoma molecular subgroups, indicating the similar correlation of the subgroups and outcomes to world-wide reports. As the Children's Neuro-Oncology Group (CNOG) was established in China in May 2017, it makes studies from multiple centers in children's brain tumors become practical. And the availability of DNA methylation array, NanoString and other methods in medulloblastoma subgroup identification assures the quality of the method for this study.